Report cover image

Is the Metaverse Virtually a Reality for Life Science R&D?

Publisher IDC
Published Mar 03, 2023
Length 8 Pages
SKU # IDC17783421

Description

Is the Metaverse Virtually a Reality for Life Science R&D?

This IDC Perspective reviews the significant potential of the metaverse and how it could transform the life science industry. It covers key use cases, analyzes the vendor landscape, reviews implementation challenges, and provides guidance to the technology buyer."As clinical trials go remote and the ask for the personal touch heightens, the metaverse will deepen patient engagement, shape patient behaviors, and transform patient and provider training. There will be increasing adoption of virtual reality in digital therapeutics to treat mental health disorders. Immersiveness will serve as a key differentiator, multiple use cases and multiple technologies will converge over time and will reshape existing models and patient experiences. On the long run, the metaverse will transform the way decentralized clinical trials are implemented. The reality is that the application of the metaverse in pharma is no more virtual," says Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy and Technology at IDC Health Insights.

Please Note: Extended description available upon request.

Table of Contents

8 Pages
Executive Snapshot
Situation Overview
Challenges Associated with the Metaverse
The Metaverse and Clinical Trials
Advice for the Technology Buyer
Learn More
Related Research
Synopsis
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.